Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

SELL
$525.19 - $619.13 $4,201 - $4,953
-8 Reduced 38.1%
13 $7,000
Q3 2023

Nov 07, 2023

SELL
$434.7 - $599.3 $425,571 - $586,714
-979 Reduced 97.9%
21 $11,000
Q2 2023

Aug 04, 2023

SELL
$350.74 - $468.98 $158,885 - $212,447
-453 Reduced 31.18%
1,000 $468,000
Q1 2023

May 03, 2023

BUY
$310.63 - $364.82 $451,345 - $530,083
1,453 New
1,453 $498,000
Q4 2021

Feb 07, 2022

SELL
$224.85 - $279.04 $406,528 - $504,504
-1,808 Closed
0 $0
Q3 2021

Oct 27, 2021

BUY
$221.6 - $272.71 $8,199 - $10,090
37 Added 2.09%
1,808 $415,000
Q2 2021

Jul 26, 2021

SELL
$180.55 - $233.54 $108,691 - $140,591
-602 Reduced 25.37%
1,771 $409,000
Q1 2021

May 07, 2021

BUY
$164.32 - $212.72 $108,122 - $139,969
658 Added 38.37%
2,373 $440,000
Q4 2020

Feb 03, 2021

SELL
$130.46 - $172.63 $103,324 - $136,722
-792 Reduced 31.59%
1,715 $284,000
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $148,559 - $171,836
1,016 Added 68.14%
2,507 $371,000
Q2 2020

Aug 11, 2020

BUY
$136.42 - $164.18 $203,402 - $244,792
1,491 New
1,491 $243,000
Q4 2018

Jan 16, 2019

SELL
$105.9 - $118.64 $71,800 - $80,437
-678 Closed
0 $0
Q3 2018

Oct 25, 2018

BUY
$85.86 - $107.31 $58,213 - $72,756
678 New
678 $73,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Advisors Preferred, LLC Portfolio

Follow Advisors Preferred, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Preferred, LLC with notifications on news.